Press Releases

MONMOUTH JUNCTION, N.J., Oct. 10, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its

SMITHS FALLS, ON, Oct. 10, 2019 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) is pleased to announce that David Klein has been appointed Chair of its Board of Directors effective immediately.

SAN FRANCISCO, Oct. 10, 2019 /PRNewswire/ -- EPIC Insurance Brokers & Consultants (Edgewood Partners Insurance Center or EPIC), a retail property and casualty insurance brokerage and employee benefits consultant, announced today the expansion and reorganization of its healthcare practice.

SAN JOSE, Calif., Oct. 10, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announc

BRUSSELS and CAMBRIDGE, Massachusetts, Oct. 10, 2019 /PRNewswire/ --Regulated Information – Inside Information – UCB and Ra Pharmaceuticals Inc. (NASDAQ: RARX, Ra Pharma) announced today their entry into a merger agreement pursuant for which UCB will acquire Ra Pharma. Under the terms of the agreement, Ra

CHICAGO, Oct. 10, 2019 /PRNewswire/ -- Impact Networking, a leading managed service provider, and Culinary Care, a nonprofit making nutritious and delicious meals easily accessible for everyone fighting cancer, announced that they are teaming up to launch the inaugural Impact Cup award. The Impact Cup will be the championship trophy awarded annually to the Corpora

(RED) partners Bank of America and Salesforce expand commitments to the Global Fund; new private sector partners join the fight LYON, France, Oct. 10, 2019 /PRNewswire/ -- At the Sixth Global Fund Replenishment, (RED) today announced an increased three-year pledge to the Global Fund of USD $150 million, up 50% from USD

EXTON, Pa., Oct. 10, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today

STOCKHOLM, Oct. 10, 2019 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today announces that the first patient has been enrolled in a phase I study to investigate the safety and tolerability of a combination treatment of birinapant and radiation therapy in patients with recurrent Head and Neck Squamous Cell Carcinoma (HNSCC). The initiative for the study

SUZHOU, China and LONDON, Oct. 10, 2019 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801) and Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) today announced the expansion of their global collaboration agreement to evaluate the safety and efficacy of Innovent's Tyvyt&re